N. Reguart Aransay - Dept. Medical Oncology, Hospital Clinic y Provincial de Barcelona

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 5 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

138P Faecalibacterium prausnitzii enhances tumor response to perioperative nivolumab and chemotherapy

A. Rodriguez-Festa, R. Serna-Blasco, E. Nadal, J.L. Gonzalez-Larriba, A. Martinez-Marti,R. Bernabe Caro, J. Bosch-Barrera, J. Casal Rubio,V. Calvo de Juan, M.A. Insa Molla,S. Ponce Aix,N. Reguart Aransay,

ESMO Open (2024)

引用0浏览0引用

1410P Characterization of patients with advanced non-small-cell lung cancer (NSCLC) harboring KRASG12C mutation and their associated direct healthcare costs in Spanish routine clinical practice (SILK study)

N. Reguart Aransay,J. Sánchez, O.J. Juan Vidal, M. Aguilo Domingo, E. Arriola, C. López, X. Botella, F. Cots, C. Montironi, S. Palanca, E. Borràs, L. Masfarre Pinto,

Annals of Oncology (2023): S806-S807

引用0浏览0引用

10 Osimertinib versus gefitinib followed by osimertinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE trial